CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 54 filers reported holding CATALYST PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $209,781 | -3.0% | 13,543 | +1.1% | 0.00% | – |
| Q1 2024 | $216,180 | +9.2% | 13,394 | +16.7% | 0.00% | – |
| Q4 2023 | $198,024 | -7.0% | 11,473 | -10.2% | 0.00% | – |
| Q1 2023 | $212,909 | -93.1% | 12,772 | -97.8% | 0.00% | -100.0% |
| Q3 2021 | $3,066,000 | -15.2% | 593,007 | -5.2% | 0.00% | -50.0% |
| Q2 2021 | $3,614,000 | +140.6% | 625,276 | +84.4% | 0.00% | +100.0% |
| Q1 2021 | $1,502,000 | +28.0% | 339,121 | -0.3% | 0.00% | 0.0% |
| Q4 2020 | $1,173,000 | +35.3% | 340,114 | +22.1% | 0.00% | 0.0% |
| Q3 2020 | $867,000 | -42.2% | 278,610 | -6.8% | 0.00% | 0.0% |
| Q2 2020 | $1,500,000 | +167.4% | 298,862 | +92.8% | 0.00% | 0.0% |
| Q1 2020 | $561,000 | -4.6% | 155,016 | -1.2% | 0.00% | – |
| Q4 2019 | $588,000 | +716.7% | 156,897 | +1065.4% | 0.00% | – |
| Q3 2019 | $72,000 | +44.0% | 13,463 | +3.9% | 0.00% | – |
| Q2 2019 | $50,000 | +92.3% | 12,953 | +159.1% | 0.00% | – |
| Q1 2019 | $26,000 | +100.0% | 5,000 | -21.4% | 0.00% | – |
| Q4 2018 | $13,000 | -40.9% | 6,361 | +12.3% | 0.00% | – |
| Q3 2018 | $22,000 | +22.2% | 5,666 | -0.3% | 0.00% | – |
| Q2 2018 | $18,000 | +50.0% | 5,685 | +13.7% | 0.00% | – |
| Q1 2018 | $12,000 | +1100.0% | 5,000 | +400.0% | 0.00% | – |
| Q4 2016 | $1,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q3 2016 | $1,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q2 2016 | $1,000 | -66.7% | 1,000 | -60.0% | 0.00% | – |
| Q1 2016 | $3,000 | -50.0% | 2,500 | 0.0% | 0.00% | – |
| Q4 2015 | $6,000 | -25.0% | 2,500 | 0.0% | 0.00% | – |
| Q3 2015 | $8,000 | +33.3% | 2,500 | +66.7% | 0.00% | – |
| Q2 2015 | $6,000 | 0.0% | 1,500 | 0.0% | 0.00% | – |
| Q1 2015 | $6,000 | +50.0% | 1,500 | 0.0% | 0.00% | – |
| Q4 2014 | $4,000 | -20.0% | 1,500 | 0.0% | 0.00% | – |
| Q3 2014 | $5,000 | +25.0% | 1,500 | 0.0% | 0.00% | – |
| Q2 2014 | $4,000 | +33.3% | 1,500 | 0.0% | 0.00% | – |
| Q1 2014 | $3,000 | 0.0% | 1,500 | 0.0% | 0.00% | – |
| Q4 2013 | $3,000 | – | 1,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 7,097,300 | $27,750,000 | 4.54% |
| GREAT POINT PARTNERS LLC | 3,817,288 | $14,926,000 | 2.55% |
| TANAKA CAPITAL MANAGEMENT INC | 256,593 | $1,003,000 | 2.29% |
| Consonance Capital Management LP | 4,473,607 | $17,492,000 | 1.58% |
| Avoro Capital Advisors LLC | 3,892,343 | $15,219,000 | 0.99% |
| KNOTT DAVID M | 380,110 | $1,486,000 | 0.59% |
| EAM Investors, LLC | 790,872 | $3,092,000 | 0.55% |
| Ghost Tree Capital, LLC | 550,000 | $2,151,000 | 0.50% |
| EAM Global Investors LLC | 251,647 | $984,000 | 0.50% |
| MANGROVE PARTNERS IM, LLC | 924,648 | $3,615,000 | 0.49% |